All News
Dupilumab for Atopic Dermatitis Linked to Increased Risk of Psoriasis
(MedPage Today) -- The use of dupilumab (Dupixent) for the treatment of atopic dermatitis was associated with an increased risk of psoriasis compared with other systemic agents, according to a retros
Read MoreOpinion: Following second patient death, Duchenne muscular dystrophy families deserve answers about Elevidys
Duchenne muscular dystrophy families are sharing stories about Elevidys complications on social media. But they aren’t getting answers from Sarepta.
Read MoreDuopoly in Dialysis Industry Has Grown, Raising Prices for Some Patients
(MedPage Today) -- The two largest dialysis chains in the U.S.
Read MoreMedicare's Go-Broke Date Pushed Up to 2033
(MedPage Today) -- The go-broke date for Medicare's trust fund has moved up amid rising healthcare costs, according to an annual report released Wednesday.
Read MoreUSMLE Raises Step 2 Pass Score
(MedPage Today) -- Starting July 1, medical students who take the U.S. Medical Licensing Examination (USMLE) Step 2 Clinical Knowledge (CK) test will just have to be a little bit smarter.
Read MoreRegulators Approve Lenacapavir for H.I.V. Prevention
The drug could change the course of the AIDS epidemic. But the Trump administration has gutted the programs that might have paid for it in low-income countries.
Read MoreSTAT+: Gilead won U.S. approval for HIV prevention shot, but when will low-income countries gain sufficient access?
Gilead has won FDA approval for an HIV prevention shot that is administered only once every six months.
Read MoreHIV protection with just two shots a year: FDA approves Gilead drug
A new twice-yearly shot could be a "game changer" in the fight against AIDS, but experts' hopes have dimmed because of the current political climate.
Read MorePsilocybin for Depressed Cancer Patients; GLP-1s With Clozapine; Global OCD Trip
(MedPage Today) -- A single dose of psilocybin combined with psychological support reduced anxiety and depression for 2 years in people with cancer and major depressive disorder in a phase II trial.
Read MoreMental health and poverty remain a struggle for Maui wildfire survivors, new study says
Two years after the devastating fires, many lack access to food, stable housing, work and healthcareMental health problems and economic hardship remain widespread among survivors of the Maui wildfire,
Read More